Über das Unternehmen
- Firmenname (rechtlich): Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.
- Registrierungsland: China
- Adresse: No. 6, Yangshan Road, Jinshanqiao Economic Zone, Xuzhou/Jiangsu
- Anzahl der Mitarbeiter: Ab 5000
Beschreibung:
Fosun Wanbang (Jiangsu) Pharmaceutical Group is an innovation-driven pharmaceutical company in China and a core member of Fosun Pharma, with business spanning pharmaceutical R&D, manufacturing, wholesale and distribution across the healthcare industry chain. Several of its production lines have passed FDA and EU site audits, with key products including human insulins, GLP-1 products, EPO and heparin sodium, along with oral solid dosage products such as ticagrelor, tofacitinib, crizotinib and osimertinib tablets, and key APIs including insulins, heparin sodium, venetoclax and febuxostat.
Geschäftsaktivitäten
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
HerstellerAPI-Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
Hauptprodukte/-dienstleistungen
- Fertigarzneiformen: Lei Wan Capsules
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Tofacitinib Tablets, Compound Aloe Capsules, Liraglutide Injection, Insulin Glargine Injection, Insulin Lispro Injection, Empagliflozin Tablets, Glimepiride Tablets, Semaglutide Injection, Human Insulin, Crizotinib Capsules, Erythropoietin for Injection (EPO), Venetoclax, Leflunomide Tablets, Roxadustat Capsules, Apixaban Tablets, Guanfacine ER Tablets, Febuxostat
Unsere Produkte & Dienstleistungen
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
GMP
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen